NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal beta-turns

J Med Chem. 1993 May 14;36(10):1450-60. doi: 10.1021/jm00062a018.

Abstract

Three tetrapeptides were prepared, each corresponding to the four C-terminal amino acid residues of highly potent, second-generation bradykinin receptor antagonists. The tetrapeptides are (IA) Ser-D-Phe-Oic-Arg, (IIA) Ser-D-Tic-Oic-Arg, and (IIIA) Ser-D-Hype(trans-propyl)-Oic-Arg. Solution conformations for each were determined by incorporating interproton distance restraints, determined by 2D NMR experiments performed in water at neutral pH, into a series of distance geometry/simulated annealing model building calculations. Similarly, systematic conformational analyses were performed for each using molecular mechanics calculations. Both the NMR-derived structures, as well as the calculated structures, are shown to adopt a beta-turn as the primary conformation. Excellent agreement between the predicted structures and the NMR-derived structures is demonstrated. Aside from being the first examples of linear tetrapeptides reported to be ordered in aqueous solvent, the results presented support the hypothesis that high-affinity bradykinin receptor antagonists must adopt C-terminal beta-turn conformations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Guinea Pigs
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Molecular Conformation
  • Molecular Sequence Data
  • Muscle, Smooth / drug effects
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Receptors, Bradykinin
  • Receptors, Neurotransmitter / antagonists & inhibitors*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Oligopeptides
  • Receptors, Bradykinin
  • Receptors, Neurotransmitter
  • seryl-phenylalanyl-octahydroindole-2-carbonyl-arginine
  • seryl-HYPE(transpropyl)-octahydroindole-2-carbonyl-arginine
  • seryl-tetrahydroisoquinolinecarbonyl-octahydroindole-2-carbonyl-arginine